Systematische ÜbersichtMetaanalyse
The Role of Biologic Therapies (Belimumab and Anifrolumab) in Systemic Lupus Erythematosus (SLE) Disease Activity and Renal Outcomes in Predominantly Young Female Trial Populations: A Systematic Review and Meta-Analysis
Cureus · 12.11.2026
DOI: 10.7759/cureus.119544 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cureus, erschienen am 12.11.2026. Verfasst von Priyanka Hayre. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hayre, P. (2026). The Role of Biologic Therapies (Belimumab and Anifrolumab) in Systemic Lupus Erythematosus (SLE) Disease Activity and Renal Outcomes in Predominantly Young Female Trial Populations: A Systematic Review and Meta-Analysis. Cureus. https://doi.org/10.7759/cureus.119544
Vancouver
Hayre P. The Role of Biologic Therapies (Belimumab and Anifrolumab) in Systemic Lupus Erythematosus (SLE) Disease Activity and Renal Outcomes in Predominantly Young Female Trial Populations: A Systematic Review and Meta-Analysis. Cureus. 2026. doi:10.7759/cureus.119544
BibTeX
@article{Hayre2026,
author = {Hayre, Priyanka},
title = {The Role of Biologic Therapies (Belimumab and Anifrolumab) in Systemic Lupus Erythematosus (SLE) Disease Activity and Renal Outcomes in Predominantly Young Female Trial Populations: A Systematic Review and Meta-Analysis},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.119544}
}
EUVIMED